Pangea Pharmaceuticals Announces U.S. Launch of Sdamlo(TM), the First and Only FDA-Approved, Amlodipine Powder for Oral Solution

Pangea Pharmaceuticals, a U.S.-based, patient-centered pharmaceutical company focused on bringing differentiated, clinically relevant products to market, today announced the U.S.
Yahoo Finance

Pangea Unveils Annual Sustainability Report

Pangea 2023 CSR Report · GlobeNewswire Inc. Rochester Hills, MI, June 03, 2024 (GLOBE NEWSWIRE) -- Pangea, a pioneering force in the automotive leather industry, proudly unveils its annual ...
Business Wire

Pangea Cyber Secures $25M Series A to Launch API-based Cloud Security Services for Application Builders

PALO ALTO, Calif.--(BUSINESS WIRE)--Pangea Cyber Corporation today emerged from stealth to announce $25M in Series A funding to become the first company to offer application builders a comprehensive ...
Science Daily

Pangea Conundrum

The existence of the supercontinent Pangea, which formed about 300 million years ago and broke up about 200 million years ago, is a cornerstone of plate tectonics, and processes resulting in its ...

Pangea Pharmaceuticals Announces U.S. Launch of Sdamlo™, the First and Only FDA-Approved, Amlodipine Powder for Oral Solution

Sdamlo, by Pangea Pharmaceuticals, is an FDA-approved amlodipine, unit-dose, alcohol-free solution for pediatric, geriatric, ...